from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1971/mce3F

LFCtreatmentdescriptionclass of inhibitor

-0.904

Amikacinug/mL Amikacintranslation

-0.670

Cap5-10ug/mL Capreomycintranslation

0.781

Rox10-50 ug/mL Roxithromycintranslation

-0.123

SM2-5 ug/mL Streptomycintranslation

-1.051

Tet5-10 ug/mL Tetracyclinetranslation

-0.223

Rif0.2-5ug/mL Rifampicintranscription

0.393

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.536

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.069

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.090

CPZ10-50 ug/mL Chlorpromazinerespiration

0.297

Clofazimine10-13 ug/mL Clofaziminerespiration

0.277

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.146

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.394

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.813

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.499

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.164

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.578

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.396

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.479

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.620

KCN5-20 ug/mL Potassium cyaniderespiration

1.785

NaN30.2-2 mM Sodium aziderespiration

0.599

Nigericin50 uM Nigericinrespiration

0.042

TRC10-150 ug/mL Triclosanrespiration

-0.476

TRZ10-25 ug/mL Thioridazinerespiration

1.037

Valinomycin0.5-10 uM Valinomycinrespiration

1.418

ZnSO42 mM ZnSO4respiration

0.220

menadione6-10 ug/mL Menadionerespiration

0.019

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.802

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.520

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.740

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.616

NRP_1Non-replicating persistence stage 1dosRassociated

-0.278

Amp0.2mg/mL AmpicillincellWall

-0.453

Cephalexin20-100 ug/mL CephalexincellWall

0.124

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.610

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.518

EMB10-20 ug/mL EthambutolcellWall

0.026

Eta12-40 ug/mL EthionamidecellWall

-0.131

INH0.2-0.4 ug/mL IsoniazidcellWall

0.180

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.374

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.729

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.410

BZA0.12 mg/mL BenzamidearomaticAmides

-0.274

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.256

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.469

H2O24 mM hydrogen peroxideDNAdamaging

-0.015

Levo10 ug/mL LevofloxacinDNAdamaging

-0.453

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.100

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.256

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.400

UVUV-irradiationDNAdamaging

0.325

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.147

Antimycin12.5-50 ug/mL Antimycin A?

-0.191

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.029

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.315

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.632

PA8240.2-2 ug/mL PA-824?

0.521

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.381

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.153

Verapamil50 uM Verapamil?

-0.096

mercaptoethanol2 mM 2-Mercaptoethanol?

0.636

methoxatin10-20 ug/mL Methoxatin?